Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 3
2011 1
2016 1
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Long-term response to successful acute pharmacological treatment of psychotic depression.
Wijkstra J, Burger H, van den Broek WW, Birkenhäger TK, Janzing JG, Boks MP, Bruijn JA, van der Loos ML, Breteler LM, Verkes RJ, Nolen WA. Wijkstra J, et al. Among authors: van der loos ml. J Affect Disord. 2010 Jun;123(1-3):238-42. doi: 10.1016/j.jad.2009.10.014. Epub 2009 Oct 31. J Affect Disord. 2010. PMID: 19880189 Clinical Trial.
Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
Wijkstra J, Burger H, van den Broek WW, Birkenhäger TK, Janzing JG, Boks MP, Bruijn JA, van der Loos ML, Breteler LM, Ramaekers GM, Verkes RJ, Nolen WA. Wijkstra J, et al. Among authors: van der loos ml. Acta Psychiatr Scand. 2010 Mar;121(3):190-200. doi: 10.1111/j.1600-0447.2009.01464.x. Epub 2009 Aug 19. Acta Psychiatr Scand. 2010. PMID: 19694628 Clinical Trial.
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU. Solmi M, et al. Among authors: van der loos ml. CNS Spectr. 2016 Oct;21(5):403-418. doi: 10.1017/S1092852916000523. CNS Spectr. 2016. PMID: 27686028
Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group. van der Loos ML, et al. Bipolar Disord. 2011 Feb;13(1):111-7. doi: 10.1111/j.1399-5618.2011.00887.x. Bipolar Disord. 2011. PMID: 21320258 Clinical Trial.